These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 7679580)

  • 1. Tissue polypeptide-specific antigen: a discriminative parameter between prostate cancer and benign prostatic hypertrophy.
    Marrink J; Oosterom R; Bonfrer HM; Schröder FH; Mensink HJ
    Eur J Cancer; 1993; 29A(4):570-1. PubMed ID: 7679580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
    Tarle M
    Anticancer Res; 1993; 13(3):769-77. PubMed ID: 7686362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue polypeptide-specific antigen (TPS) immunoassay in the diagnosis and clinical staging of prostatic carcinoma. Comparison with prostate-specific antigen (PSA).
    Ceriani L; Giovanella L; Salvadore M; Bono AV; Roncari G
    Int J Biol Markers; 1997; 12(1):27-34. PubMed ID: 9176715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of cell proliferation marker (TPS), natural killer (NK) activity and tumor load serotest (PSA) in untreated and treated prostatic tumors.
    Tarle M; Kovacić K; Kastelan M
    Anticancer Res; 1993; 13(1):215-8. PubMed ID: 7682800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer.
    Benson MC; Whang IS; Pantuck A; Ring K; Kaplan SA; Olsson CA; Cooner WH
    J Urol; 1992 Mar; 147(3 Pt 2):815-6. PubMed ID: 1371554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokeratin 8/18 levels in patients with prostate cancer and benign prostatic hyperplasia.
    Wolff JM; Borchers H; Brehmer B; Brauers A; Jakse G
    Urol Int; 1998; 60(3):152-5. PubMed ID: 9644784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen (PSA) and cancer-associated serum antigen (CASA) in distinguishing benign and malignant prostate disease.
    Devine PL; Walsh MD; McGuckin MA; Quin RJ; Hohn BG; Clague A; Samaratunga H
    Int J Biol Markers; 1995; 10(4):221-5. PubMed ID: 8750649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
    Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM
    Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A more objective staging of advanced prostate cancer--routine recognition of malignant endocrine structures: the assessment of serum TPS, PSA, and NSE values.
    Tarle M; Frković-Grazio S; Kraljić I; Kovacić K
    Prostate; 1994; 24(3):143-8. PubMed ID: 7509485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen in prostatic cancer.
    Baron JC; Peyret C; Leroy M; Teillac P; Najean Y; Le Duc A
    Am J Clin Oncol; 1988; 11 Suppl 2():S75-6. PubMed ID: 2468279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of PSA/IGF-1 ratio in differentiating benign prostate hyperplasia from prostate cancer.
    Koliakos G; Chatzivasiliou D; Dimopoulos T; Trachana V; Paschalidou K; Galiamoutsas V; Triantos A; Chitas G; Dimopoulos A; Vlatsas G
    Dis Markers; 2000; 16(3-4):143-6. PubMed ID: 11381196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of benign prostatic hyperplasia and prostate cancer employing prostatic-specific antigen density.
    Wolff JM; Scholz A; Boeckmann W; Jakse G
    Eur Urol; 1994; 25(4):295-8; discussion 304. PubMed ID: 7519991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of prostate-specific antigen density as a diagnostic test of prostate cancer.
    Filella X; Alcover J; Molina R; Carrere W; Carretero P; Ballesta AM
    Tumour Biol; 1996; 17(1):20-6. PubMed ID: 7501969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
    Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
    Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-relation between measurement of serum prostatic specific antigen and transrectal ultrasound in the diagnosis of benign prostatic hyperplasia and prostatic cancer.
    Clements R; Etherington RJ; Griffiths GJ; Peeling WB; Hughes H; Penney MD
    Br J Urol; 1992 Aug; 70(2):183-7. PubMed ID: 1382795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and discriminative ability of prostate-specific antigen as a tumor marker.
    Leitenberger A; Altwein JE
    Eur Urol; 1990; 17(1):12-6. PubMed ID: 1690653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurements of free and total PSA, tissue polypeptide-specific antigen (TPS), and CYFRA 21-1 in prostate cancer patients under intermittent androgen suppression therapy.
    Theyer G; Dürer A; Theyer U; Haberl I; Ulsperger E; Baumgartner G; Hamilton G
    Prostate; 1999 Oct; 41(2):71-7. PubMed ID: 10477903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of the PSA-concentration for the detection of prostate cancer].
    Stachon A
    Pathologe; 2005 Nov; 26(6):469-72. PubMed ID: 16195861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free and total PSA in the diagnosis of prostate cancer.
    Filella X; Alcover J; Molina R; Rodríguez A; Carretero P; Ballesta AM
    Tumour Biol; 1997; 18(6):332-40. PubMed ID: 9372866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of prostate specific antigen and gamma-seminoprotein ratio: a new means of distinguishing benign prostatic hyperplasia and prostate cancer.
    Demura T; Watarai Y; Togashi M; Hirano T; Ohashi N; Koyanagi T
    J Urol; 1993 Nov; 150(5 Pt 2):1740-5. PubMed ID: 7692111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.